John Nelson of GE Research Talks Vaccines on Demand, Enzymatic Synthesis, and the Era of Writing DNA
Today we talk with John Nelson, Senior Principal Scientist at GE Research and veteran in the...
37:14
John Nelson of GE Research Talks Vaccines on Demand, Enzymatic Synthesis, and the Era of Writing DNA
Today we talk with John Nelson, Senior Principal Scientist at GE Research and veteran in the...
37:14
“I’ve seen a lot of revolutions. Now we’re at the beginning of spatial biology, and I think it...
39:28
Enabling a New Age of Unbiased Proteomics Discovery: Omid Farokhzad, Seer Inc.
Are we now entering the age of proteomics the way we did with genomics thirty years ago? We were...
45:22
The Rise of MRD Testing and the Field of Fragmentomics with Sugganth Daniel, Invitae
"There's an entire field of fragmentomics with a whole lot of people working on it. The DNA...
35:17
The Invention of Enzymatic DNA Synthesis with Sylvain Gariel, DNA Script
The DNA synthesis space is seeing some real creativity and disruption this past year. One...
28:08
Even though Brian McKelligon calls himself a rookie CEO, he comes to the top position at Akoya...
30:24
Harlan Robins on How T-cell Focused COVID Vaccines Can Move Us Toward Endemicity
Harlan Robins is the Chief Scientific Officer at Adaptive Biotechnologies in Seattle. In 2014,...
31:11
Twist Bioscience: A New Kind of DNA Synthesis Company
“DNA is changing everything for the better,” says today’s guest, Emily Leproust, CEO of Twist...
39:15
Twist Bioscience: A New Kind of DNA Synthesis Company
“DNA is changing everything for the better,” says today’s guest, Emily Leproust, CEO of Twist...
39:15
Going High Resolution with 10X Genomics: Michael Schnall-Levin
Working at the Broad Institute early in his career, Michael Schnall Levin was discovering he was...
37:32
George Church and Ben Lamm on the Launch of Colossal Biosciences
According to scientists, 30,000 species per year are going extinct. That’s 6 an hour, 150 per...
41:08
We Might Be the Comeback Kids of the Universe: Chris Mason on His Plan for the Next 500 Years
Chris Mason is back on the program for our end-of-year special. He’s Professor of Genomics,...
47:10
Invitae and PacBio CEOs Share Details of Clinical Sequencing Partnership
In a joint interview, Sean George, CEO of diagnostics firm, Invitae, and Christian Henry, CEO of...
52:34
Invitae and PacBio CEOs Share Details of Clinical Sequencing Partnership
In a joint interview, Sean George, CEO of diagnostics firm, Invitae, and Christian Henry, CEO of...
52:53
LuminexPLORE Lab Offers Community of Developers Custom Insights: Jackie Surls, Director
There are some technologies that become so ubiquitous in biomedical research that their name...
23:28
DNA Script Takes DNA Synthesis Back to the Bench with Enzymatic Tech: Thomas Ybert, CEO
DNA is a multibillion-dollar industry in 2021 and satisfies many life science applications,...
28:30
Tumor Evolution in Context with Christina Curtis
If one was going to be a cancer researcher, surely one would want to be Christina Curtis. She’s...
29:28
The History of mRNA Vaccines with Elie Dolgin
"Scientists have been putting RNA into cells through a lipid delivery system for 44 years,” says...
44:37
“Why do plants make a host of chemicals they don’t use? One answer that has always intrigued me...
29:31
Quantitative Pathology with David Rimm, Yale
David Rimm, Professor of Pathology at Yale, was doing spatial biology since before it was called...
27:30
The wisdom of the Gritty Nurses
Episodio
New to What On Earth? Start here!
Episodio
#386: Συνέντευξη Ν. Λυγερού
Episodio